their best (lowest) price in some cases, a percentage below average price in others. Many theoretical models have shown that … product's characteristics match the incentives in the law. I find that after the MFC rule was implemented the average price of … branded products facing generic competition rose - the median presentation's price rose about 4%. Brands protected by patents …

models show that an MFC rule commits a firm to compete less aggressively in prices. I find that the price of branded products … facing generic competition rose (4% on average). Brands protected by patents did not significantly increase in price … firms raise price more as their markets become concentrated. Hospital prices show little change. The results suggest that …

analyses the public insurance of a patent-protected pharmaceutical product in terms of price controls and socially optimal … third-degree price discrimination. First, the paper characterizes the Ramsey pricing rule in the case where the producer … price has to cover the R&D costs of the firm and patients’ pharmaceutical expenditures are not covered by health insurance …

, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal … third-degree price discrimination. It characterizes first the Ramsey pricing rule in the absence of insurance and in the … case where the producer price has to cover the R&D sunk cost of the firm. Subsequently, conditions for a welfare increasing …

Erstattungsbetragsverhandlungen innovativer Arzneimittel werden als Gefahr für die zukünftige Versorgung der Patienten und für den Forschungs- und … zweckmäßigen Vergleichstherapie gleichwertige Arzneimittel schlechter gestellt werden. Zum anderen können nur noch … Arzneimittel beeinflusst darüber hinaus die Standortentscheidungen pharmazeutischer Unternehmen. …